XARELTO(rivaroxaban)

AFib stroke prevention; DVT/PE treatment and prevention; ACS; CAD/PAD risk reduction.

1 DTP program

From $197/mo

1 platform

FDA-Approved Indications

Reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillationTreatment and risk reduction of recurrent DVT and PERisk reduction of major CV events in patients with CAD or PAD

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

Cash-pay (self-pay)

via J&J Direct · Johnson & Johnson

$197/mo

$197/30ct (all strengths: 10mg, 15mg, 20mg priced identically). $591/90ct. Insurance not accepted. Licensed from Bayer HealthCare AG. Prices may change at any time without notice.

Eligibility

US resident (incl. Puerto Rico & U.S. Virgin Islands). Valid prescription required. Open to all insurance statuses. Phone enrollment only: (855) 522-3241 or HCP fax (888) 975-0603.

May purchase at cash price. Cannot submit claims to or seek reimbursement from Medicare, Medicaid, TRICARE, DoD, or VA. Costs do not count toward Part D TrOOP or any deductible.

Visit Program

Last verified: Mar 2026